Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Colitis, Ulcerative | 70 | 2024 | 1919 | 10.680 |
Why?
|
Crohn Disease | 66 | 2023 | 2275 | 9.290 |
Why?
|
Colitis, Microscopic | 20 | 2024 | 72 | 8.590 |
Why?
|
Inflammatory Bowel Diseases | 52 | 2024 | 2420 | 6.400 |
Why?
|
Colitis, Collagenous | 10 | 2024 | 25 | 4.210 |
Why?
|
Colitis, Lymphocytic | 11 | 2024 | 23 | 3.970 |
Why?
|
Contraceptives, Oral | 7 | 2022 | 554 | 2.760 |
Why?
|
Sweden | 33 | 2024 | 1376 | 2.090 |
Why?
|
Gastrointestinal Agents | 10 | 2020 | 508 | 1.330 |
Why?
|
Celiac Disease | 6 | 2024 | 822 | 1.220 |
Why?
|
Diverticulum | 2 | 2020 | 137 | 1.190 |
Why?
|
Colorectal Neoplasms | 15 | 2023 | 6852 | 1.150 |
Why?
|
Prospective Studies | 71 | 2023 | 54136 | 1.130 |
Why?
|
Risk Factors | 79 | 2024 | 73806 | 1.110 |
Why?
|
Sick Leave | 4 | 2020 | 105 | 1.090 |
Why?
|
Estrogen Replacement Therapy | 4 | 2018 | 1206 | 1.070 |
Why?
|
Biological Therapy | 7 | 2021 | 139 | 0.990 |
Why?
|
Incidence | 39 | 2023 | 21273 | 0.950 |
Why?
|
Reproductive History | 3 | 2018 | 211 | 0.950 |
Why?
|
Colitis | 3 | 2024 | 1231 | 0.880 |
Why?
|
Intra-Abdominal Fat | 2 | 2018 | 608 | 0.820 |
Why?
|
Budesonide | 3 | 2021 | 158 | 0.810 |
Why?
|
Tuberculosis, Gastrointestinal | 2 | 2019 | 21 | 0.810 |
Why?
|
Proportional Hazards Models | 25 | 2022 | 12440 | 0.800 |
Why?
|
Gastroenteritis | 2 | 2021 | 236 | 0.780 |
Why?
|
Tooth Loss | 1 | 2023 | 198 | 0.780 |
Why?
|
Diet | 8 | 2023 | 8003 | 0.760 |
Why?
|
Registries | 17 | 2021 | 8176 | 0.750 |
Why?
|
Humans | 184 | 2024 | 758381 | 0.710 |
Why?
|
Middle Aged | 98 | 2024 | 219560 | 0.710 |
Why?
|
Adult | 106 | 2024 | 219916 | 0.700 |
Why?
|
Glutens | 2 | 2021 | 240 | 0.690 |
Why?
|
Periodontal Diseases | 1 | 2023 | 451 | 0.690 |
Why?
|
Dehydroepiandrosterone Sulfate | 2 | 2022 | 240 | 0.660 |
Why?
|
Case-Control Studies | 27 | 2024 | 22031 | 0.650 |
Why?
|
Female | 124 | 2024 | 390316 | 0.650 |
Why?
|
Colonoscopy | 10 | 2024 | 1388 | 0.630 |
Why?
|
Colectomy | 4 | 2019 | 692 | 0.620 |
Why?
|
Prevalence | 15 | 2024 | 15646 | 0.610 |
Why?
|
Follow-Up Studies | 33 | 2023 | 39060 | 0.600 |
Why?
|
Proton Pump Inhibitors | 4 | 2020 | 529 | 0.600 |
Why?
|
Diphosphonates | 2 | 2013 | 636 | 0.590 |
Why?
|
Proctitis | 1 | 2017 | 41 | 0.590 |
Why?
|
Sex Hormone-Binding Globulin | 2 | 2022 | 546 | 0.590 |
Why?
|
Bismuth | 2 | 2018 | 28 | 0.540 |
Why?
|
Iron, Dietary | 1 | 2017 | 148 | 0.540 |
Why?
|
Salicylates | 2 | 2018 | 127 | 0.520 |
Why?
|
Clostridium Infections | 3 | 2018 | 557 | 0.520 |
Why?
|
Disease Progression | 8 | 2019 | 13468 | 0.520 |
Why?
|
Colonic Diseases | 1 | 2017 | 200 | 0.520 |
Why?
|
Aged | 63 | 2024 | 168217 | 0.510 |
Why?
|
Feces | 9 | 2024 | 1457 | 0.500 |
Why?
|
Vegetables | 2 | 2020 | 1194 | 0.500 |
Why?
|
Heme | 1 | 2017 | 313 | 0.500 |
Why?
|
Alcohol Drinking | 3 | 2022 | 4020 | 0.490 |
Why?
|
Feeding Behavior | 4 | 2022 | 3183 | 0.490 |
Why?
|
Androgens | 1 | 2022 | 1291 | 0.480 |
Why?
|
Obesity | 7 | 2021 | 12870 | 0.480 |
Why?
|
Male | 92 | 2024 | 358742 | 0.470 |
Why?
|
Abdominal Pain | 3 | 2019 | 1063 | 0.460 |
Why?
|
GTP-Binding Proteins | 1 | 2018 | 950 | 0.460 |
Why?
|
Health Resources | 1 | 2020 | 931 | 0.460 |
Why?
|
Acetaminophen | 1 | 2018 | 552 | 0.450 |
Why?
|
Genetic Predisposition to Disease | 7 | 2022 | 17768 | 0.440 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 3 | 2020 | 2270 | 0.440 |
Why?
|
Smoking | 9 | 2022 | 9042 | 0.430 |
Why?
|
Colonic Polyps | 3 | 2023 | 551 | 0.430 |
Why?
|
Tumor Necrosis Factor-alpha | 8 | 2020 | 4342 | 0.420 |
Why?
|
Diet, Mediterranean | 1 | 2020 | 736 | 0.420 |
Why?
|
Testosterone | 3 | 2022 | 2471 | 0.420 |
Why?
|
Young Adult | 37 | 2024 | 58808 | 0.420 |
Why?
|
Organometallic Compounds | 2 | 2018 | 648 | 0.410 |
Why?
|
Bacterial Infections | 1 | 2021 | 1401 | 0.410 |
Why?
|
Metagenomics | 3 | 2024 | 457 | 0.400 |
Why?
|
Weight Gain | 2 | 2020 | 2346 | 0.390 |
Why?
|
Vitamin B 12 | 1 | 2015 | 523 | 0.390 |
Why?
|
Cohort Studies | 32 | 2023 | 41252 | 0.390 |
Why?
|
Menopause | 2 | 2018 | 1639 | 0.380 |
Why?
|
Immunosuppressive Agents | 4 | 2021 | 4158 | 0.380 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 4 | 2021 | 3227 | 0.380 |
Why?
|
Digestive System Surgical Procedures | 2 | 2016 | 575 | 0.380 |
Why?
|
Microsatellite Instability | 1 | 2015 | 715 | 0.380 |
Why?
|
Risk Assessment | 24 | 2021 | 23883 | 0.380 |
Why?
|
Body Mass Index | 8 | 2018 | 12876 | 0.370 |
Why?
|
Health Surveys | 8 | 2018 | 4060 | 0.370 |
Why?
|
Polymorphism, Single Nucleotide | 10 | 2023 | 15773 | 0.360 |
Why?
|
Adenoma | 4 | 2023 | 2148 | 0.360 |
Why?
|
Age of Onset | 7 | 2020 | 3298 | 0.350 |
Why?
|
Multivariate Analysis | 15 | 2018 | 12096 | 0.340 |
Why?
|
Postmenopause | 3 | 2017 | 2509 | 0.340 |
Why?
|
Patient Compliance | 1 | 2020 | 2685 | 0.330 |
Why?
|
Adolescent | 33 | 2024 | 87888 | 0.320 |
Why?
|
Colon | 4 | 2024 | 1788 | 0.310 |
Why?
|
ABO Blood-Group System | 1 | 2011 | 367 | 0.310 |
Why?
|
Biopsy | 13 | 2024 | 6768 | 0.310 |
Why?
|
Nurses | 7 | 2021 | 2467 | 0.310 |
Why?
|
Health Care Costs | 2 | 2023 | 3245 | 0.300 |
Why?
|
Pensions | 2 | 2019 | 15 | 0.290 |
Why?
|
Risk | 6 | 2023 | 9599 | 0.290 |
Why?
|
Carcinoma, Hepatocellular | 4 | 2021 | 2292 | 0.290 |
Why?
|
Life Style | 3 | 2017 | 3886 | 0.280 |
Why?
|
Chronic Disease | 4 | 2022 | 9266 | 0.280 |
Why?
|
Adiposity | 1 | 2017 | 1858 | 0.280 |
Why?
|
Dietary Fiber | 3 | 2023 | 759 | 0.280 |
Why?
|
Remission Induction | 3 | 2024 | 2388 | 0.270 |
Why?
|
Anti-Inflammatory Agents | 2 | 2016 | 1793 | 0.270 |
Why?
|
Absenteeism | 2 | 2020 | 249 | 0.260 |
Why?
|
Constipation | 2 | 2024 | 561 | 0.260 |
Why?
|
Severity of Illness Index | 9 | 2021 | 15785 | 0.260 |
Why?
|
Odds Ratio | 8 | 2024 | 9650 | 0.250 |
Why?
|
Prognosis | 14 | 2021 | 29558 | 0.250 |
Why?
|
Logistic Models | 9 | 2018 | 13276 | 0.250 |
Why?
|
Metagenome | 3 | 2024 | 450 | 0.250 |
Why?
|
Irritable Bowel Syndrome | 2 | 2021 | 453 | 0.250 |
Why?
|
Age Factors | 7 | 2021 | 18357 | 0.250 |
Why?
|
Estradiol | 2 | 2022 | 1933 | 0.240 |
Why?
|
Diabetes Mellitus | 2 | 2015 | 5818 | 0.240 |
Why?
|
United States | 25 | 2024 | 72140 | 0.240 |
Why?
|
Aged, 80 and over | 20 | 2021 | 58681 | 0.240 |
Why?
|
Hospitalization | 9 | 2021 | 10653 | 0.230 |
Why?
|
Siblings | 3 | 2023 | 824 | 0.230 |
Why?
|
Liver Neoplasms | 4 | 2021 | 4313 | 0.230 |
Why?
|
Population Surveillance | 4 | 2020 | 2606 | 0.230 |
Why?
|
Quality of Life | 4 | 2021 | 13286 | 0.230 |
Why?
|
Motor Activity | 1 | 2013 | 2686 | 0.220 |
Why?
|
Hepatitis B, Chronic | 2 | 2019 | 403 | 0.220 |
Why?
|
Diabetes Mellitus, Type 1 | 2 | 2023 | 3432 | 0.220 |
Why?
|
Hip Fractures | 1 | 2012 | 987 | 0.220 |
Why?
|
Surgical Procedures, Operative | 1 | 2015 | 1911 | 0.210 |
Why?
|
Massachusetts | 5 | 2018 | 8823 | 0.210 |
Why?
|
Intestinal Mucosa | 3 | 2024 | 3023 | 0.210 |
Why?
|
Time Factors | 14 | 2021 | 39873 | 0.200 |
Why?
|
Hypertension | 1 | 2022 | 8503 | 0.200 |
Why?
|
Histamine H2 Antagonists | 2 | 2020 | 165 | 0.190 |
Why?
|
Diarrhea | 4 | 2021 | 1317 | 0.190 |
Why?
|
Sigmoidoscopy | 2 | 2019 | 151 | 0.190 |
Why?
|
C-Reactive Protein | 4 | 2016 | 3812 | 0.180 |
Why?
|
Aspirin | 3 | 2020 | 3132 | 0.180 |
Why?
|
Exercise | 1 | 2017 | 5788 | 0.180 |
Why?
|
Manitoba | 1 | 2020 | 24 | 0.180 |
Why?
|
Diet Surveys | 3 | 2020 | 1161 | 0.180 |
Why?
|
Intestine, Large | 1 | 2019 | 68 | 0.170 |
Why?
|
Second-Look Surgery | 1 | 2019 | 27 | 0.170 |
Why?
|
Work | 1 | 2020 | 194 | 0.160 |
Why?
|
Cecum | 1 | 2019 | 233 | 0.160 |
Why?
|
Adenomatous Polyps | 1 | 2019 | 108 | 0.160 |
Why?
|
Bacteria | 3 | 2024 | 2199 | 0.150 |
Why?
|
Appendectomy | 2 | 2022 | 431 | 0.150 |
Why?
|
Comorbidity | 7 | 2021 | 10495 | 0.150 |
Why?
|
Ruminococcus | 1 | 2017 | 11 | 0.150 |
Why?
|
Gonadal Steroid Hormones | 1 | 2022 | 701 | 0.150 |
Why?
|
Antidiarrheals | 1 | 2018 | 46 | 0.150 |
Why?
|
Retrospective Studies | 20 | 2021 | 80170 | 0.150 |
Why?
|
Fatty Liver | 1 | 2024 | 777 | 0.150 |
Why?
|
Dietary Fats | 2 | 2017 | 1991 | 0.150 |
Why?
|
Unemployment | 1 | 2019 | 208 | 0.150 |
Why?
|
Dinoprostone | 1 | 2020 | 598 | 0.140 |
Why?
|
Rhinitis, Allergic, Seasonal | 1 | 2018 | 104 | 0.140 |
Why?
|
Mesalamine | 1 | 2018 | 136 | 0.140 |
Why?
|
Anti-Bacterial Agents | 5 | 2022 | 7403 | 0.140 |
Why?
|
Fruit | 2 | 2020 | 1159 | 0.140 |
Why?
|
Parkinson Disease | 2 | 2021 | 2862 | 0.140 |
Why?
|
Phenotype | 3 | 2022 | 16534 | 0.140 |
Why?
|
Drug Monitoring | 2 | 2020 | 960 | 0.140 |
Why?
|
Microsatellite Repeats | 2 | 2016 | 785 | 0.130 |
Why?
|
Fluorocarbons | 1 | 2021 | 489 | 0.130 |
Why?
|
Fatigue | 2 | 2020 | 1542 | 0.130 |
Why?
|
Defecation | 1 | 2017 | 190 | 0.130 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2022 | 1016 | 0.130 |
Why?
|
Quantitative Trait Loci | 1 | 2023 | 2100 | 0.130 |
Why?
|
Appendicitis | 1 | 2022 | 674 | 0.130 |
Why?
|
Patient Care Management | 1 | 2018 | 302 | 0.130 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2022 | 1503 | 0.120 |
Why?
|
Cardiovascular Diseases | 3 | 2023 | 15396 | 0.120 |
Why?
|
Natural Language Processing | 1 | 2024 | 1135 | 0.120 |
Why?
|
Anticarcinogenic Agents | 1 | 2017 | 249 | 0.120 |
Why?
|
Laxatives | 1 | 2015 | 92 | 0.120 |
Why?
|
Tetracycline | 1 | 2015 | 219 | 0.120 |
Why?
|
Rosacea | 1 | 2015 | 59 | 0.120 |
Why?
|
Cause of Death | 3 | 2020 | 3674 | 0.120 |
Why?
|
Ostomy | 1 | 2014 | 29 | 0.120 |
Why?
|
Longitudinal Studies | 4 | 2020 | 14481 | 0.120 |
Why?
|
Eosinophilic Esophagitis | 1 | 2018 | 192 | 0.120 |
Why?
|
Anus Diseases | 1 | 2014 | 55 | 0.120 |
Why?
|
Canada | 1 | 2020 | 2111 | 0.120 |
Why?
|
Genetic Loci | 2 | 2021 | 2612 | 0.120 |
Why?
|
Fecal Incontinence | 1 | 2017 | 241 | 0.120 |
Why?
|
Treatment Outcome | 15 | 2020 | 64379 | 0.120 |
Why?
|
Immunocompromised Host | 1 | 2019 | 856 | 0.110 |
Why?
|
Endoscopy, Gastrointestinal | 2 | 2017 | 867 | 0.110 |
Why?
|
Disability Evaluation | 2 | 2018 | 1825 | 0.110 |
Why?
|
Ileum | 1 | 2016 | 555 | 0.110 |
Why?
|
Endoscopy, Digestive System | 1 | 2016 | 351 | 0.110 |
Why?
|
Cross-Sectional Studies | 6 | 2021 | 25953 | 0.110 |
Why?
|
Risk Reduction Behavior | 1 | 2020 | 1098 | 0.110 |
Why?
|
Single-Cell Analysis | 1 | 2024 | 2379 | 0.110 |
Why?
|
Beverages | 1 | 2018 | 818 | 0.100 |
Why?
|
Steroids | 1 | 2018 | 926 | 0.100 |
Why?
|
Radiography, Thoracic | 1 | 2019 | 1296 | 0.100 |
Why?
|
Methotrexate | 1 | 2019 | 1719 | 0.100 |
Why?
|
Adrenal Cortex Hormones | 3 | 2016 | 1870 | 0.100 |
Why?
|
Peptic Ulcer | 1 | 2014 | 217 | 0.100 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2018 | 12076 | 0.100 |
Why?
|
Myocardial Ischemia | 1 | 2023 | 2108 | 0.100 |
Why?
|
Disabled Persons | 2 | 2019 | 1224 | 0.100 |
Why?
|
Antigen Presentation | 1 | 1997 | 1254 | 0.100 |
Why?
|
Constriction, Pathologic | 1 | 2015 | 1097 | 0.100 |
Why?
|
Iran | 1 | 2015 | 737 | 0.100 |
Why?
|
Government Programs | 1 | 2014 | 279 | 0.100 |
Why?
|
Biological Products | 1 | 2021 | 906 | 0.100 |
Why?
|
Fever | 1 | 2019 | 1617 | 0.100 |
Why?
|
Zinc | 1 | 2015 | 687 | 0.100 |
Why?
|
Sleep | 3 | 2016 | 4745 | 0.090 |
Why?
|
Hepatitis C, Chronic | 1 | 2019 | 1031 | 0.090 |
Why?
|
Child | 14 | 2024 | 79813 | 0.090 |
Why?
|
Genome-Wide Association Study | 6 | 2024 | 12604 | 0.090 |
Why?
|
Recurrence | 4 | 2016 | 8426 | 0.090 |
Why?
|
Fetus | 1 | 1997 | 1860 | 0.090 |
Why?
|
Pedigree | 1 | 2018 | 4578 | 0.090 |
Why?
|
Vitamin D | 2 | 2016 | 3283 | 0.090 |
Why?
|
Food Hypersensitivity | 1 | 2018 | 697 | 0.090 |
Why?
|
Antineoplastic Agents | 1 | 2013 | 13591 | 0.090 |
Why?
|
Child, Preschool | 7 | 2024 | 42058 | 0.090 |
Why?
|
Mortality | 1 | 2021 | 2885 | 0.090 |
Why?
|
Fatty Acids | 1 | 2017 | 1803 | 0.080 |
Why?
|
Geography | 1 | 2012 | 659 | 0.080 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2013 | 487 | 0.080 |
Why?
|
Mucous Membrane | 2 | 2023 | 656 | 0.080 |
Why?
|
Gastrointestinal Diseases | 1 | 2017 | 1185 | 0.080 |
Why?
|
Gene Expression Regulation | 2 | 2023 | 11894 | 0.080 |
Why?
|
Women's Health | 1 | 2019 | 2057 | 0.080 |
Why?
|
Guideline Adherence | 1 | 2019 | 2215 | 0.080 |
Why?
|
Affect | 1 | 2016 | 1480 | 0.080 |
Why?
|
Glucocorticoids | 1 | 2018 | 2144 | 0.080 |
Why?
|
Smoking Cessation | 2 | 2018 | 2049 | 0.080 |
Why?
|
Sex Characteristics | 1 | 2019 | 2621 | 0.080 |
Why?
|
Stroke | 2 | 2023 | 9696 | 0.080 |
Why?
|
Gene Frequency | 1 | 2015 | 3612 | 0.080 |
Why?
|
Breast Feeding | 2 | 2014 | 1355 | 0.080 |
Why?
|
Vitamins | 1 | 2016 | 1632 | 0.070 |
Why?
|
Patient Acceptance of Health Care | 1 | 2021 | 3175 | 0.070 |
Why?
|
Liver Cirrhosis | 3 | 2024 | 1930 | 0.070 |
Why?
|
Hyperglycemia | 1 | 2016 | 1368 | 0.070 |
Why?
|
Diagnosis, Differential | 3 | 2019 | 12951 | 0.070 |
Why?
|
Antirheumatic Agents | 1 | 2016 | 1368 | 0.070 |
Why?
|
Forecasting | 1 | 2016 | 2920 | 0.070 |
Why?
|
Histocompatibility Antigens Class II | 2 | 2024 | 1446 | 0.070 |
Why?
|
Iron | 1 | 2015 | 1786 | 0.070 |
Why?
|
Quality of Health Care | 1 | 2021 | 4317 | 0.070 |
Why?
|
Genes, Tumor Suppressor | 1 | 2010 | 1055 | 0.070 |
Why?
|
Interleukin-6 | 1 | 2016 | 3208 | 0.060 |
Why?
|
Heart Failure | 2 | 2023 | 11594 | 0.060 |
Why?
|
Infant, Newborn | 5 | 2019 | 26182 | 0.060 |
Why?
|
Critical Illness | 2 | 2016 | 2703 | 0.060 |
Why?
|
Carcinoma | 1 | 2017 | 2330 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 3 | 2019 | 20500 | 0.060 |
Why?
|
Length of Stay | 2 | 2016 | 6439 | 0.060 |
Why?
|
Gene Expression | 1 | 2018 | 7583 | 0.060 |
Why?
|
Early Detection of Cancer | 1 | 2019 | 3211 | 0.060 |
Why?
|
Birth Weight | 1 | 2013 | 2097 | 0.060 |
Why?
|
Cost of Illness | 1 | 2014 | 1936 | 0.060 |
Why?
|
Gene Silencing | 1 | 2010 | 1507 | 0.060 |
Why?
|
Analgesics, Opioid | 1 | 2020 | 3765 | 0.060 |
Why?
|
Brain Ischemia | 1 | 2017 | 3047 | 0.060 |
Why?
|
Gastrointestinal Transit | 1 | 2024 | 99 | 0.060 |
Why?
|
Infant, Premature | 1 | 2013 | 2092 | 0.050 |
Why?
|
Lung | 2 | 2019 | 9985 | 0.050 |
Why?
|
Cognition Disorders | 1 | 2017 | 3975 | 0.050 |
Why?
|
Echinococcosis | 1 | 2002 | 31 | 0.050 |
Why?
|
Common Variable Immunodeficiency | 1 | 2024 | 102 | 0.050 |
Why?
|
Genotype | 4 | 2018 | 12945 | 0.050 |
Why?
|
Macrophages | 1 | 1997 | 5737 | 0.050 |
Why?
|
Propensity Score | 2 | 2021 | 1907 | 0.050 |
Why?
|
Osteoporosis | 1 | 2012 | 1599 | 0.050 |
Why?
|
Bile Acids and Salts | 1 | 2024 | 383 | 0.050 |
Why?
|
Insulin Resistance | 1 | 2016 | 3941 | 0.050 |
Why?
|
Vitamin D Deficiency | 1 | 2011 | 1377 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2019 | 7377 | 0.050 |
Why?
|
Residence Characteristics | 1 | 2012 | 2058 | 0.050 |
Why?
|
Adenocarcinoma | 1 | 2019 | 6313 | 0.050 |
Why?
|
Intensive Care Units | 1 | 2015 | 3732 | 0.050 |
Why?
|
Peptide Elongation Factors | 1 | 2001 | 62 | 0.050 |
Why?
|
Morbidity | 2 | 2018 | 1754 | 0.050 |
Why?
|
DNA Methylation | 2 | 2016 | 4373 | 0.050 |
Why?
|
Infant | 5 | 2024 | 36054 | 0.040 |
Why?
|
Clinical Pharmacy Information Systems | 1 | 2020 | 102 | 0.040 |
Why?
|
Self Report | 3 | 2020 | 3712 | 0.040 |
Why?
|
Boston | 3 | 2018 | 9304 | 0.040 |
Why?
|
Treatment Failure | 2 | 2016 | 2640 | 0.040 |
Why?
|
Environmental Exposure | 1 | 2014 | 4411 | 0.040 |
Why?
|
Cognition | 1 | 2017 | 6955 | 0.040 |
Why?
|
Double-Blind Method | 3 | 2020 | 12262 | 0.040 |
Why?
|
Pacific Ocean | 1 | 2019 | 15 | 0.040 |
Why?
|
Sex Factors | 3 | 2018 | 10505 | 0.040 |
Why?
|
Blood | 1 | 2021 | 586 | 0.040 |
Why?
|
Insurance, Disability | 1 | 2018 | 27 | 0.040 |
Why?
|
Regression Analysis | 2 | 2021 | 6353 | 0.040 |
Why?
|
Thrombospondins | 1 | 2019 | 193 | 0.040 |
Why?
|
Leukocytes, Mononuclear | 1 | 2005 | 1826 | 0.040 |
Why?
|
Immunologic Factors | 2 | 2019 | 1585 | 0.040 |
Why?
|
HLA Antigens | 1 | 2024 | 1368 | 0.040 |
Why?
|
Gene Expression Regulation, Fungal | 1 | 2001 | 498 | 0.040 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2019 | 398 | 0.040 |
Why?
|
Enterocytes | 1 | 2019 | 220 | 0.040 |
Why?
|
Metabolic Networks and Pathways | 1 | 2022 | 786 | 0.040 |
Why?
|
Reproducibility of Results | 1 | 2016 | 20052 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2022 | 13245 | 0.040 |
Why?
|
MicroRNAs | 1 | 2013 | 3783 | 0.040 |
Why?
|
New Zealand | 1 | 2018 | 352 | 0.040 |
Why?
|
Linear Models | 2 | 2018 | 5861 | 0.040 |
Why?
|
Drug Therapy, Combination | 2 | 2019 | 6293 | 0.040 |
Why?
|
Gene Expression Profiling | 3 | 2024 | 9405 | 0.040 |
Why?
|
Animals | 4 | 2018 | 167777 | 0.040 |
Why?
|
Asia | 1 | 2019 | 616 | 0.040 |
Why?
|
Liver | 3 | 2021 | 7502 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2019 | 10747 | 0.040 |
Why?
|
Antigens, Differentiation, B-Lymphocyte | 1 | 1997 | 317 | 0.040 |
Why?
|
Proteomics | 2 | 2021 | 3816 | 0.040 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2005 | 3774 | 0.030 |
Why?
|
Depression | 2 | 2016 | 8057 | 0.030 |
Why?
|
Ovarian Neoplasms | 1 | 2013 | 4876 | 0.030 |
Why?
|
Hybridomas | 1 | 1997 | 442 | 0.030 |
Why?
|
Mice, Inbred C3H | 1 | 1997 | 915 | 0.030 |
Why?
|
Butyrates | 1 | 2017 | 169 | 0.030 |
Why?
|
Ileitis | 1 | 2016 | 39 | 0.030 |
Why?
|
Capsules | 1 | 2016 | 191 | 0.030 |
Why?
|
Antibodies, Monoclonal | 3 | 2019 | 9160 | 0.030 |
Why?
|
Weight Loss | 2 | 2019 | 2671 | 0.030 |
Why?
|
Prostaglandins | 1 | 2017 | 398 | 0.030 |
Why?
|
Survival Rate | 3 | 2020 | 12721 | 0.030 |
Why?
|
Freezing | 1 | 2016 | 306 | 0.030 |
Why?
|
Carcinoma, Renal Cell | 1 | 2010 | 3217 | 0.030 |
Why?
|
Hormones | 1 | 2019 | 869 | 0.030 |
Why?
|
Netherlands | 1 | 2020 | 2212 | 0.030 |
Why?
|
Mice, Inbred Strains | 1 | 1997 | 1759 | 0.030 |
Why?
|
Australia | 1 | 2018 | 1235 | 0.030 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2010 | 8506 | 0.030 |
Why?
|
North America | 1 | 2018 | 1276 | 0.030 |
Why?
|
Diabetes Complications | 1 | 2021 | 1317 | 0.030 |
Why?
|
Cytokines | 2 | 2021 | 7338 | 0.030 |
Why?
|
Gastritis | 1 | 2016 | 199 | 0.030 |
Why?
|
Medical History Taking | 1 | 2018 | 772 | 0.030 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 1997 | 1125 | 0.030 |
Why?
|
Kidney Neoplasms | 1 | 2010 | 4312 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2016 | 15638 | 0.030 |
Why?
|
Survival | 1 | 2013 | 160 | 0.030 |
Why?
|
Brain Diseases | 1 | 2002 | 1541 | 0.030 |
Why?
|
SEER Program | 1 | 2019 | 1530 | 0.030 |
Why?
|
Liver Function Tests | 1 | 2015 | 523 | 0.030 |
Why?
|
Species Specificity | 1 | 2017 | 2417 | 0.030 |
Why?
|
Survival Analysis | 2 | 2016 | 10112 | 0.030 |
Why?
|
Immunoglobulin Fab Fragments | 1 | 2015 | 444 | 0.030 |
Why?
|
Interleukin-17 | 1 | 2019 | 908 | 0.030 |
Why?
|
Sex Distribution | 1 | 2018 | 2283 | 0.030 |
Why?
|
Metabolome | 1 | 2020 | 982 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 2 | 2019 | 36285 | 0.030 |
Why?
|
Retirement | 1 | 2014 | 197 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2019 | 15225 | 0.030 |
Why?
|
GTP Phosphohydrolases | 1 | 2016 | 517 | 0.030 |
Why?
|
Integrins | 1 | 2017 | 836 | 0.030 |
Why?
|
Genome, Bacterial | 1 | 2017 | 770 | 0.030 |
Why?
|
Plasma | 1 | 2016 | 584 | 0.030 |
Why?
|
Seafood | 1 | 2015 | 390 | 0.030 |
Why?
|
Age Distribution | 1 | 2018 | 2882 | 0.030 |
Why?
|
Biostatistics | 1 | 2014 | 164 | 0.030 |
Why?
|
Alanine Transaminase | 1 | 2015 | 604 | 0.030 |
Why?
|
Promoter Regions, Genetic | 2 | 2016 | 5779 | 0.030 |
Why?
|
Epithelial Cells | 1 | 2024 | 3665 | 0.020 |
Why?
|
Gastrointestinal Tract | 1 | 2018 | 830 | 0.020 |
Why?
|
Metabolomics | 1 | 2021 | 1629 | 0.020 |
Why?
|
Genetic Markers | 1 | 2018 | 2608 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2018 | 3425 | 0.020 |
Why?
|
Immunoglobulin E | 1 | 2018 | 1484 | 0.020 |
Why?
|
Europe | 1 | 2018 | 3420 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2018 | 2359 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2016 | 1829 | 0.020 |
Why?
|
Algorithms | 2 | 2024 | 13959 | 0.020 |
Why?
|
Immunophenotyping | 1 | 2016 | 1871 | 0.020 |
Why?
|
Efficiency | 1 | 2014 | 477 | 0.020 |
Why?
|
Clinical Protocols | 1 | 2017 | 1436 | 0.020 |
Why?
|
T-Lymphocytes | 2 | 2019 | 10171 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 2019 | 1894 | 0.020 |
Why?
|
Helicobacter pylori | 1 | 2014 | 376 | 0.020 |
Why?
|
Meta-Analysis as Topic | 1 | 2015 | 1373 | 0.020 |
Why?
|
Women | 1 | 2012 | 225 | 0.020 |
Why?
|
ROC Curve | 1 | 2018 | 3563 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2024 | 4549 | 0.020 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2024 | 3071 | 0.020 |
Why?
|
Phylogeny | 1 | 2017 | 2774 | 0.020 |
Why?
|
Adiponectin | 1 | 2016 | 1114 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 1997 | 1664 | 0.020 |
Why?
|
Saccharomyces cerevisiae | 1 | 2001 | 2695 | 0.020 |
Why?
|
Arthritis, Rheumatoid | 1 | 2005 | 3755 | 0.020 |
Why?
|
Neoplasms | 1 | 2019 | 22030 | 0.020 |
Why?
|
HIV Infections | 1 | 2016 | 17275 | 0.020 |
Why?
|
Collagen | 1 | 2018 | 2635 | 0.020 |
Why?
|
Quality Indicators, Health Care | 1 | 2019 | 1797 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2017 | 4839 | 0.020 |
Why?
|
Polyethylene Glycols | 1 | 2015 | 1188 | 0.020 |
Why?
|
Drug Resistance, Bacterial | 1 | 2016 | 1055 | 0.020 |
Why?
|
Psychomotor Performance | 1 | 2017 | 1878 | 0.020 |
Why?
|
Glucose | 1 | 2001 | 4336 | 0.020 |
Why?
|
Tobacco Smoke Pollution | 1 | 2014 | 812 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 1997 | 6209 | 0.020 |
Why?
|
Neoplasm Proteins | 1 | 2001 | 3609 | 0.020 |
Why?
|
Stress, Physiological | 1 | 2016 | 1398 | 0.020 |
Why?
|
Administration, Oral | 1 | 2016 | 3993 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2010 | 877 | 0.020 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2016 | 1725 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2017 | 1878 | 0.020 |
Why?
|
Employment | 1 | 2014 | 1112 | 0.020 |
Why?
|
Memory | 1 | 2017 | 2179 | 0.020 |
Why?
|
Attention | 1 | 2017 | 2387 | 0.020 |
Why?
|
Schools | 1 | 2015 | 1482 | 0.020 |
Why?
|
Eating | 1 | 2013 | 1536 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2016 | 2717 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2017 | 3100 | 0.020 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2016 | 2053 | 0.020 |
Why?
|
Pediatrics | 1 | 2021 | 3587 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2016 | 5199 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2018 | 3615 | 0.020 |
Why?
|
Alleles | 1 | 2016 | 6895 | 0.020 |
Why?
|
Genetic Testing | 1 | 2018 | 3530 | 0.020 |
Why?
|
Radiography | 1 | 2016 | 6955 | 0.020 |
Why?
|
Inpatients | 1 | 2016 | 2551 | 0.010 |
Why?
|
Health Status | 1 | 2017 | 4069 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2017 | 7023 | 0.010 |
Why?
|
Health Personnel | 1 | 2018 | 3311 | 0.010 |
Why?
|
Databases, Factual | 1 | 2019 | 7980 | 0.010 |
Why?
|
Cell Line | 1 | 1997 | 15594 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2001 | 9575 | 0.010 |
Why?
|
Kidney Failure, Chronic | 1 | 2016 | 2457 | 0.010 |
Why?
|
Pilot Projects | 1 | 2016 | 8554 | 0.010 |
Why?
|
Iraq | 1 | 2002 | 94 | 0.010 |
Why?
|
Hospitals | 1 | 2016 | 3888 | 0.010 |
Why?
|
Rupture, Spontaneous | 1 | 2002 | 353 | 0.010 |
Why?
|
Anxiety | 1 | 2016 | 4538 | 0.010 |
Why?
|
Blood Glucose | 1 | 2016 | 6347 | 0.010 |
Why?
|
Insulin | 1 | 2016 | 6578 | 0.010 |
Why?
|
Transcription Factors | 1 | 2001 | 12096 | 0.010 |
Why?
|
Genomics | 1 | 2017 | 5789 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2019 | 9273 | 0.010 |
Why?
|
Research Design | 1 | 2017 | 6154 | 0.010 |
Why?
|
Inflammation | 1 | 2020 | 10719 | 0.010 |
Why?
|
Transcriptional Elongation Factors | 1 | 2001 | 164 | 0.010 |
Why?
|
Endosomal Sorting Complexes Required for Transport | 1 | 2001 | 150 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2016 | 6457 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2016 | 7843 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2015 | 10146 | 0.010 |
Why?
|
Genome, Human | 1 | 2010 | 4415 | 0.010 |
Why?
|
Conserved Sequence | 1 | 2001 | 1165 | 0.010 |
Why?
|
Protein Subunits | 1 | 2001 | 942 | 0.010 |
Why?
|
RNA Polymerase II | 1 | 2001 | 537 | 0.010 |
Why?
|
Fungal Proteins | 1 | 2001 | 911 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2001 | 2753 | 0.010 |
Why?
|
Sequence Alignment | 1 | 2001 | 2176 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 2001 | 4169 | 0.010 |
Why?
|
Mammals | 1 | 2001 | 1132 | 0.010 |
Why?
|
Mice | 2 | 2001 | 81107 | 0.010 |
Why?
|
Reoperation | 1 | 2002 | 4282 | 0.010 |
Why?
|
Drosophila melanogaster | 1 | 2001 | 1709 | 0.010 |
Why?
|
Caenorhabditis elegans | 1 | 2001 | 1444 | 0.010 |
Why?
|
Mutation | 1 | 2016 | 29915 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2001 | 6520 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2005 | 18942 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2001 | 13447 | 0.010 |
Why?
|
Peptide Fragments | 1 | 2001 | 5098 | 0.000 |
Why?
|
Molecular Sequence Data | 1 | 2001 | 17617 | 0.000 |
Why?
|
Rats | 1 | 2001 | 23681 | 0.000 |
Why?
|
Signal Transduction | 1 | 2005 | 23341 | 0.000 |
Why?
|